Skip to main content

Month: September 2021

Cabaletta Bio to Participate in Upcoming Investor Conferences in September

PHILADELPHIA, Sept. 02, 2021 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today announced that the Company will participate in two upcoming investor conferences in September:Morgan Stanley 19th Annual Global Healthcare Conference: Steven Nichtberger, M.D., President and Chief Executive Officer, will participate in a fireside chat on Thursday, September 9, 2021 at 1:15 p.m. ET. Members of management will also be available for one-on-one meetings.H.C. Wainwright 23rd Annual Global Investment Conference: Steven Nichtberger, M.D., President and Chief Executive Officer, will participate in a pre-recorded fireside chat, which will become available for on-demand...

Continue reading

Bolt Biotherapeutics to Participate in Upcoming September Investor Conferences

REDWOOD CITY, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biotechnology company pioneering a new class of immuno-oncology agents that combine the targeting precision of antibodies with the power of both the innate and adaptive immune systems, today announced that management will present a corporate update and conduct meetings with the investment community at four upcoming virtual investor conferences in September:Citi’s 16th Annual BioPharma Virtual ConferenceMeetings with investors on Wednesday, Sept. 8Wells Fargo Virtual Healthcare ConferencePresentation on Thursday, Sept. 9, at 12:30 p.m. PT (3:20 p.m. ET)Morgan Stanley 19th Annual Global Healthcare ConferenceFireside chat on Monday, Sept. 13, at 12:30 p.m. PT (3:30 p.m. ET)2021 Cantor Fitzgerald Virtual Global Healthcare...

Continue reading

Lantheus Holdings to Present at Upcoming Investor Conferences

NORTH BILLERICA, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to find, fight and follow serious medical conditions, today announced Mary Anne Heino, President and Chief Executive Officer, and Bob Marshall, Chief Financial Officer and Treasurer, will present at the following investor conferences.Wells Fargo 2021 Virtual Healthcare ConferenceSeptember 9, 2021 at 4 p.m. ETBaird 2021 Global Healthcare ConferenceSeptember 15, 2021 at 7:55 a.m. ETTo access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s...

Continue reading

Advantage Solutions to Participate at Upcoming Barclays Global Consumer Staples Conference

IRVINE, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) — Advantage Solutions Inc. (NASDAQ: ADV) (“Advantage,” the “Company,” “we” or “our”), the leading provider of outsourced sales and marketing services to consumer goods companies and retailers, today announced that its management team will attend the Barclays Global Consumer Staples Conference on September 10, 2021. Investors who are interested in setting up a meeting may contact Advantage Investor Relations or their Barclays conference representative. About Advantage Solutions Advantage Solutions is a leading business solutions provider committed to driving growth for consumer goods manufacturers and retailers through winning insights and execution. Advantage’s data and technology-enabled omnichannel solutions — including sales, retail merchandising, business intelligence, digital...

Continue reading

PMV Pharmaceuticals to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

CRANBURY, N.J., Sept. 02, 2021 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, today announced that David H. Mack, Ph.D., President & Chief Executive Officer, will present at the Morgan Stanley 19th Annual Global Healthcare Conference taking place September 9-10 and 13-15, 2021. The company will also participate in one-on-one investor meetings at the conference. Details on the presentation can be found below.Morgan Stanley 19th Annual Global Healthcare ConferenceDate: Thursday, September 9th, 2021Time: 4:15pm ETAbout PMV Pharma PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting...

Continue reading

Cidara Therapeutics to Host Research and Development Day

Virtual event will highlight the broad potential of the Cloudbreak® platform and the commercial potential for rezafungin Clinical thought leaders will highlight the risks of invasive fungal infections in cancer patients, and the unmet medical need in respiratory viral diseases Webinar to be held on Tuesday, September 21st at 10:00am ET SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting compounds designed to transform the standard of care for prevention and treatment of serious diseases, today announced that it will host a research and development day webinar on Tuesday, September 21, 2021 from 10am to 12pm Eastern Time. The webinar will feature presentations by clinical thought leaders Mark James Levis, M.D., Ph.D., and Kieren Marr, M.D., both from...

Continue reading

Jounce Therapeutics to Present at Upcoming Investor Conferences in September

CAMBRIDGE, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that company management will participate at several upcoming investor conferences in September:2021 Wells Fargo Virtual Healthcare Conference: Fireside chat on Friday September 10, 2021 at 8:00 a.m. ET. H.C. Wainwright 23rd Annual Global Investment Conference: Presentation will be available on-demand during the conference, starting on Monday, September 13, 2021 at 7:00 a.m. ET. Baird’s 2021 Global Healthcare Conference: Presentation on Wednesday, September 15, 2021 at 12:15 p.m. ET.  2021 Cantor Fitzgerald Virtual Global Healthcare Conference: Presentation on Wednesday, September 29, 2021 at 4:00...

Continue reading

NETSOL Technologies to Present at the 10th Annual Gateway Conference on September 8, 2021

CALABASAS, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) — NETSOL Technologies, Inc. (Nasdaq: NTWK), a global business services and enterprise application solutions provider, has been invited to present at the 10th Annual Gateway Conference, which is being held virtually on September 8-9, 2021. NETSOL management is scheduled to present on Wednesday, September 8th at 12:30 p.m. Pacific time, with one-on-one meetings to be held throughout the conference. The presentation will be webcast live and available for replay here. To receive additional information, request an invitation or to schedule a one-on-one meeting, please email conference@gatewayir.com. About the Gateway Conference For the past nine years, the Gateway Conference has engaged the management teams of nearly 800 public and private growth companies and thousands of institutional...

Continue reading

Kymera Therapeutics to Present at Upcoming September Investor Conferences

WATERTOWN, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced that the Company will present at two upcoming investor conferences:Morgan Stanley 19th Annual Global Healthcare Conference: a fireside chat webcast will be available live on Thursday, September 9, 2021 at 1:15 p.m. ET. H.C. Wainwright 23rd Annual Global Investment Conference: an on demand webcast presentation will be available beginning on Monday, September 13, 2021 at 7:00 a.m. ET.Presentation webcasts will be available under “Events and Presentations” in the Investors section of the Company’s website at www.kymeratx.com. Archived webcast replays will be available...

Continue reading

Gentherm Invests in Electric Sensor Technology Company Forciot

NORTHVILLE, Mich., Sept. 02, 2021 (GLOBE NEWSWIRE) — Gentherm (NASDAQ: THRM), a global market leader and developer of innovative thermal management technologies, announced that it has invested in Forciot, a Finnish-based technology developer of sensors for touch, motion and force measurement. The technology being developed by Forciot has the potential to be integrated into vehicle interiors, including into steering wheels for Hands on Detection (HOD) functionality for Advanced Driver Assistance Systems (ADAS). Forciot’s innovative stretchable and printed sensors and advanced electronics are targeted to help accurately measure touch, motion and force. Forciot’s sensors may be used to sense an occupant’s presence and potentially to replace buttons and other Human-Machine Interfaces (HMI) within vehicle interiors. “The automotive...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.